熱門資訊> 正文
PetMed Express进一步推迟10-K，调查汽车运输投诉
2025-07-01 20:57
- Shares of PetMed Express (NASDAQ:PETS) are under pressure ahead of Tuesday’s open after the company disclosed that it would have to further delay Q4 and FY25 results as it continues to compile, review, and analyze the information necessary to complete its 2025 10-K.
- The company had originally filed for an extension to July 1.
- Specifically, the Board of Directors’ audit committee has received anonymous reports regarding the timing of revenue recognition of its autoship orders in Q4, some of which resulted in customer complaints.
- PetMed Express (NASDAQ:PETS) is also investigating a Q4 $50 coupon promotion and its potential impact on key performance indicators regarding new customers, as well as the company’s culture and control environment, all of which have encouraged the advice of legal counsel.
- Based on evidence gathered so far, these events are unlikely to have a material impact on preliminary Q4 results or previously filed financial results.
More on PetMed Express
- PetMed Express sees Q4 net sales between $51.1M and $53.1M
- Earnings week ahead: KR, ACN, ACB, and more
- Seeking Alpha’s Quant Rating on PetMed Express
- Historical earnings data for PetMed Express
- Financial information for PetMed Express
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
